Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
07/11/2012 | CN102552434A Preparation method and production method of angelica Jianzhong decoction integrated new formulation |
07/11/2012 | CN102552380A Novel traditional Chinese medicine for treating hypoleucocytosis caused by radiotherapy and chemotherapy for treating cancers and preparation method thereof |
07/11/2012 | CN102552372A Novel purpose of eucommia chemical components as blood vessel protective agent |
07/11/2012 | CN102552351A Preparation method and production method of Chuanxiong decoction integrated new formulation |
07/11/2012 | CN102552335A Traditional Chinese medicine health care product, its preparation method and its application |
07/11/2012 | CN102552321A Hemostatic suppository and preparation method thereof |
07/11/2012 | CN102552308A Application of campsis radicans polysaccharide to preparation of anticoagulant medicines |
07/11/2012 | CN102552272A Method for treating sepsis |
07/11/2012 | CN102552263A Methods of increasing endogenous erythropoietin EPO |
07/11/2012 | CN102552262A Methods of increasing endogenous erythropoietin EPO |
07/11/2012 | CN102552261A Methods of increasing endogenous erythropoietin EPO |
07/11/2012 | CN102552193A Andrographolide tablet and preparation method thereof |
07/11/2012 | CN102552184A Thrombopoietin peptide analogue freeze-dried preparation |
07/11/2012 | CN102552175A Fludarabine phosphate lyophilized preparation for injection and preparation method thereof |
07/11/2012 | CN102552165A Sarpogrelate hydrochloride sustained release pellet and preparation method thereof |
07/11/2012 | CN102552153A Orally-taken tuckahoe polysaccharide sulfate-chitosan nanoparticle and preparation method thereof |
07/11/2012 | CN102552149A Calcium heparin liposome preparation for injection |
07/11/2012 | CN102552148A Potassium chloride liposome injection |
07/11/2012 | CN102552135A Method for preparing vitamin K1 emulsion, and vitamin K1 emulsion |
07/11/2012 | CN102552108A Liquid suppository and preparation method thereof |
07/11/2012 | CN102551893A Method for promoting fast recovery from abdominal surgery by aid of hypokalemia preventing and controlling system |
07/11/2012 | CN102178725B Melilotus officinalis total saponin, preparation method thereof and medicinal application |
07/11/2012 | CN102078417B Traditional Chinese medicine fructus sophorae suppository for treating hemorrhoid hematochezia and preparation method thereof |
07/11/2012 | CN102008558B Application of thalictrum foeniculaceum extract in preparation of medicaments for treating blood diseases |
07/11/2012 | CN101966199B Application of campanumoea polysaccharide in preparation of medicament and health care food |
07/11/2012 | CN101829258B Chinese medicinal composition preparation for strengthening spleen and stomach, enriching blood and promoting secretion of body fluid and quality control method |
07/11/2012 | CN101675080B An erythropoietin mimetic peptide derivatives and its pharmaceutical salt, the preparation and uses thereof |
07/11/2012 | CN101392218B Nutrient health wine brewed by natural honey and Chinese herbal medicine and preparation method thereof |
07/11/2012 | CN101243870B Health food maintaining stable state normally of blood of human body |
07/10/2012 | US8217146 Neurotrophic factors and methods of use thereof |
07/10/2012 | US8217138 Anti-inflammatory compounds and uses thereof |
07/10/2012 | US8217026 Substituted porphyrins |
07/10/2012 | US8216997 Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators |
07/10/2012 | CA2592995C 1-thio-d-glucitol derivatives |
07/10/2012 | CA2520893C Process for the preparation of 1-n-(phenyl)-2-n-(phenyl)pyrrolidine-1,2-dicarboxamide derivatives and 1-(phenylcarbamoyl)pyrrolidine-2-carboxylic acid derivatives as intermediates |
07/10/2012 | CA2462930C Remodeling and glycoconjugation of peptides |
07/10/2012 | CA2446951C Polythiourea lipid derivatives |
07/10/2012 | CA2444704C Synthesis and evaluation of phthalimide mimics as anti-angiogenic agents |
07/10/2012 | CA2417960C Method of using diketopiperazines and composition containing them |
07/10/2012 | CA2319327C Sterile complex of therapeutic peptide bond to a polysaccharide |
07/10/2012 | CA2253664C Methods and devices for providing acoustic hemostasis |
07/10/2012 | CA2194172C Neurturin and related growth factors |
07/05/2012 | WO2012091041A1 Insulin secretion promoter |
07/05/2012 | WO2012090220A1 Heterocyclic compounds suitable for the treatment of dyslipidemia |
07/05/2012 | WO2012089180A1 Form c of prasugrel hydrobromide and a method for its production |
07/05/2012 | WO2012088563A1 Vegfr-2-specific forms of vegf-d and vegf-c and uses thereof |
07/05/2012 | WO2011110876A8 Novel salts for the manufacture of pharmaceutical compositions |
07/05/2012 | US20120172591 Inhibitors of human phosphatidylinositol 3-kinase delta |
07/05/2012 | US20120172448 Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof |
07/05/2012 | US20120172427 (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide tablet formulations with improved stability |
07/05/2012 | US20120172425 Red yeast rice extract high in monacolin k content |
07/05/2012 | US20120172399 Compounds as hypoxia mimetics, and composiitons and uses thereof |
07/05/2012 | US20120172396 2-adamantylurea derivatives as selective 11b-hsd1 inhibitors |
07/05/2012 | US20120172395 Slow-release cilostazol tablet having an improved elution rate and minimal side effects |
07/05/2012 | US20120172374 Novel tubulin inhibitors and methods of using the same |
07/05/2012 | US20120172352 Pyrazoline dione derivatives as nadph oxidase inhibitors |
07/05/2012 | US20120172339 Angiogenic resorcinol derivatives |
07/05/2012 | US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
07/05/2012 | US20120172335 Substituted benzimidazolone derivatives, medicaments comprising them and their use |
07/05/2012 | US20120172305 Retro-inverso peptides derived from interleukin-6 |
07/05/2012 | US20120171765 Factor VII or VIIa - Like Molecules |
07/05/2012 | US20120171284 Celecoxib compositions |
07/05/2012 | US20120171282 Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders |
07/05/2012 | US20120171262 Pharmaceutical formulations |
07/05/2012 | US20120171234 Novel Biologically Active Peptides and their New Uses |
07/05/2012 | US20120171233 Peptide inhibitors for mediating stress responses |
07/05/2012 | US20120171202 Rage Fusion Proteins And Methods Of Use |
07/05/2012 | US20120171199 Tricyclic pi3k inhibitor compounds and methods of use |
07/05/2012 | US20120171195 Anti-hla-e antibodies, therapeutic immunomodulatory antibodies to human hla-e heavy chain, useful as ivig mimetics and methods of their use |
07/05/2012 | US20120171175 Methods for treating refractory infections in neutropenic individuals |
07/05/2012 | US20120171168 Method for treating pancreatitis with mesenchymal stem cells |
07/05/2012 | US20120171118 Treatment of meningeal and neural diseases |
07/05/2012 | US20120171116 Arginase Inhibitors and Methods of Use Thereof |
07/05/2012 | CA2820854A1 Heterocyclic compounds suitable for the treatment of dyslipidemia |
07/04/2012 | EP2471792A1 3-(biaryloxy) propionic acid derivative |
07/04/2012 | EP2471542A1 Therapeutic agent for liver-related diseases |
07/04/2012 | EP2471536A1 Steroid analogs and characterization and treatment methods |
07/04/2012 | EP2471510A1 Liquid formulation of G-CSF |
07/04/2012 | EP2470670A1 Coagulation factor vii compositions and methods of making and using same |
07/04/2012 | EP2470559A1 Coagulation factor ix compositions and methods of making and using same |
07/04/2012 | EP2470530A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
07/04/2012 | EP2470193A1 Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates |
07/04/2012 | EP1874306B1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
07/04/2012 | EP1485094B1 Dosage form for oral administration of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester or its salts |
07/04/2012 | CN1964703B Immediate release pharmaceutical tablets with height greater than width |
07/04/2012 | CN1962641B Metalloproteinase inhibitors |
07/04/2012 | CN1449386B Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
07/04/2012 | CN102549000A Fused thiazolo and oxazolo pyrimidinones |
07/04/2012 | CN102548543A Slow-release cilostazol tablet having an improved elution rate and minimal side effects |
07/04/2012 | CN102533917A Method for preparing RGD (arginine glycine aspartate) active polypeptide from collagen |
07/04/2012 | CN102533702A Antidotes for factor XA inhibitors and methods of using the same |
07/04/2012 | CN102532297A Ancylostoma caninum anticoagulant peptide and preparation and application thereof |
07/04/2012 | CN102532265A Gramicidin, isomer thereof and application thereof |
07/04/2012 | CN102532161A Prasugrel phenyl sulfonate and preparation method thereof |
07/04/2012 | CN102532135A Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors |
07/04/2012 | CN102532134A Azaindoles useful as inhibitors of janus kinases |
07/04/2012 | CN102532110A Quinazoline derivative and application of serving as cell apoptosis inhibitor |
07/04/2012 | CN102531875A 3-Oxo-1,2-naphthoquinone analogues, preparation method and application thereof |
07/04/2012 | CN102526796A Absorbable haemostatic material prepared based on rat tail collagen and preparation method of same |
07/04/2012 | CN102526726A Myoglobin immunoadsorbent and immunoadsorption device |